JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3329
CAS [1801503-93-4]
MF C22H21N3O3MW 375.42
ODM-207 is a highly potent, selective and orally active pan-BET inhibitor that has shown preclinical evidence of tumour growth inhibition in breast cancer and in leukaemia and prostate cancer xenograft models.
KEYWORDS: ODM-207 | supplier | BET inhibitor | ODM207 | ODM 207 | CAS [1801503-93-4] | Histone | BET (BRD) | Inhibitor | Proteins | Prostate cancer | Breast cancer
6-(3,5-Dimethylisoxazol-4-yl)-7-methoxy-3-methyl-1-(pyridin-2-ylmethyl)quinolin-2(1H)-one
[1801503-93-4]
Potent and selective BET bromodomain inhibitor
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields